House Publications
The Debates are the report—transcribed, edited, and corrected—of what is said in the House. The Journals are the official record of the decisions and other transactions of the House. The Order Paper and Notice Paper contains the listing of all items that may be brought forward on a particular sitting day, and notices for upcoming items.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
|
|
|
Notice PaperNo. 224 Tuesday, September 26, 2023 10:00 a.m. |
|
|
|
|
Introduction of Government Bills |
|
Introduction of Private Members' Bills |
|
Notices of Motions (Routine Proceedings) |
|
| September 25, 2023 — Mr. Gourde (Lévis—Lotbinière) — That the ninth report of the Standing Committee on Access to Information, Privacy and Ethics, presented on Tuesday, June 20, 2023, be concurred in. |
|
|
| September 25, 2023 — Ms. Lewis (Haldimand—Norfolk) — That the 14th report of the Standing Committee on Transport, Infrastructure and Communities, presented on Wednesday, September 20, 2023, be concurred in. |
|
|
| September 25, 2023 — Mr. McLean (Calgary Centre) — That the ninth report of the Standing Committee on Environment and Sustainable Development, presented on Tuesday, June 20, 2023, be concurred in. |
|
|
| September 25, 2023 — Mr. Vidal (Desnethé—Missinippi—Churchill River) — That the 10th report of the Standing Committee on Indigenous and Northern Affairs, presented on Wednesday, June 21, 2023, be concurred in. |
|
|
| September 25, 2023 — Mr. Vidal (Desnethé—Missinippi—Churchill River) — That the ninth report of the Standing Committee on Indigenous and Northern Affairs, presented on Friday, June 16, 2023, be concurred in. |
Questions |
|
| Q-17462 — September 25, 2023 — Mr. Kelly (Calgary Rocky Ridge) — With regard to military aid that Canada has provided to Ukraine following Russia’s invasion thereof: (a) how many 105mm artillery shells were produced in Canada each year between 2016 and 2023 inclusively; (b) how many 105mm artillery shells has Canada provided to Ukraine; (c) how many 105mm artillery shells does Canada plan to maintain in stock following cessation of deliveries to Ukraine; (d) how many years will it take, at current production levels, to reach the target number in (c); (e) how many facilities in Canada currently manufacture 105mm artillery shells for purchase by Canada; (f) how many facilities in Canada manufactured 105mm artillery shells between 2016 and 2023 inclusively; (g) of the facilities in (f), how many do not currently manufacture 105mm artillery shells but can resume doing so if reopened, refurbished, or retooled; (h) how many 105mm artillery shells has Canada ordered from facilities in Canada that are intended for delivery to Ukraine; and (i) how many 105mm shells has Canada ordered from facilities in Canada to meet the target number in (c)? |
| Q-17472 — September 25, 2023 — Mr. Kelly (Calgary Rocky Ridge) — With regard to military aid that Canada has provided to Ukraine following Russia’s invasion thereof: (a) how many 155mm artillery shells were produced in Canada each year between 2016 and 2023 inclusively; (b) how many 155mm artillery shells has Canada provided to Ukraine; (c) how many 155mm artillery shells does Canada plan to maintain in stock following the cessation of deliveries to Ukraine; (d) how many years will it take, at current production levels, to reach the target number in (c); (e) how many facilities in Canada currently manufacture 155mm artillery shells for purchase by Canada; (f) how many facilities in Canada manufactured 155mm artillery shells between 2016 and 2023 inclusively; (g) of the facilities in (f), how many do not currently manufacture 155mm artillery shells but can resume doing so if reopened, refurbished, or retooled; (h) how many 155mm artillery shells has Canada ordered from facilities in Canada that are intended for delivery to Ukraine; (i) how many 155mm shells has Canada ordered from facilities in Canada to meet the target number in (c); (j) how many offers has Canada received for assistance to bring facilities in Canada up to capacity to manufacture 155mm artillery shells; (k) what is the dollar value of each offer in (j); and (l) of the offers in (j), which ones has Canada accepted, if any? |
| Q-17482 — September 25, 2023 — Ms. McPherson (Edmonton Strathcona) — With regard to the government’s participation in negotiations for a pandemic instrument or treaty: (a) what is Canada’s current position on the pandemic treaty, specifically with regard to equitable access to medical countermeasures such as drugs and vaccines, in particular (i) why Canada has proposed that technology transfers to enable other countries to manufacture their own drugs and vaccines only occur on “voluntary and mutually agreed terms” with pharmaceutical companies, even when those drugs and vaccines were developed with public funding from the government, (ii) what Canada proposes to do in situations where pharmaceutical companies do not enter into voluntary agreements, as it frequently did not happen during the COVID-19 pandemic and previous global public health crises such as HIV, (iii) how will Canada ensure that investments of public funds, including those by Canadian taxpayers, in pharmaceutical research, development, and manufacturing, delivers affordable and globally-accessible drugs, vaccines, and other health technologies to Canadians and people worldwide; (b) how is the government implementing the recommendations from the Standing Committee on Foreign Affairs and International Development vaccine equity report entitled “Overcoming the Barriers to Global Vaccine Equity and Ending the Pandemic” during its participation in negotiations for the pandemic instrument, and will the government follow the report’s recommendation 8 that it “ensure that its agreements to provide research and development funding include clauses that allow intellectual property resulting from that funding – including vaccines, therapeutics, and diagnostics – to be easily licensed to manufacturers serving low- and middle income countries”; (c) how are the positions articulated by civil society during the Pandemic Instrument Partner and Stakeholder Engagement Forum reflected in Canada’s own positions in negotiation of the pandemic instrument; (d) which of the strategies and actions recommended by participants and contained in the government’s report on the Pandemic Instrument Partner and Stakeholder Engagement Forum does the government agree with; (e) which of the strategies and actions recommended by participants and contained in the government’s report on the Pandemic Instrument Partner and Stakeholder Engagement Forum does the government disagree with and why; and (f) how many meetings, emails and phone calls, and on what dates, have officials from (i) Global Affairs Canada, (ii) the Public Health Agency of Canada, (iii) Health Canada, (iv) the Privy Council Office, (v) Public Services and Procurement Canada, (vi) Innovation, Science and Economic Development Canada, (vii) the Office of the Prime Minister, had with (A) Innovative Medicines Canada, (B) pharmaceutical company representatives, (C) Canadian and international not-for-profit or charitable organizations, on the subject of pandemic instrument and the revision of the International Health Regulations? |
| Q-17492 — September 25, 2023 — Ms. McPherson (Edmonton Strathcona) — With regard to the government’s procurement of vaccines during the COVID-19 pandemic: (a) what price did Canada negotiate per vaccine from each manufacturer, and what was the final price paid per vaccine for each manufacturer; (b) what were the amounts, in Canadian dollars, broken down by vaccine product and company, of advance payments made by the government to pharmaceutical companies to guarantee vaccine shipments; (c) what confidentiality and indemnification clauses did Canada agree to in order to exempt companies from legal liability; (d) were pharmaceutical companies exempted from the obligation to give full refunds if deliveries were delayed or cancelled; (e) what clauses, if any, did the vaccine purchase contracts signed by Canada include relating to the ability of Canada to donate vaccine doses from those contracts to low- and middle-income countries, humanitarian organizations, Gavi, the World Health Organization, or any other organization for use outside of Canada; (f) when Canada’s Chief Public Health Officer indicated, in October 2021, that initial agreements between Canada and the manufacturers of mRNA vaccines (e.g. Moderna and Pfizer/BioNTech) did not allow for doses to be donated but that new arrangements had been made to permit donations, what were the original conditions and the subsequently agreed conditions, respectively; (g) what is the total value, in Canadian dollars, of funding provided by the government, broken down by department or agency, to support the research, development, or manufacture of vaccines, drugs, or diagnostic tests for COVID-19 between 2020 and 2023; (h) for any of the funding provided during this time to companies, universities, not-for-profits, or other research, development, or manufacturing entities, did any of the funding agreements or contracts contain clauses or stipulations that would secure a pricing structure for the final product for Canadians or for people living in low- and middle-income countries; (i) did Canada attempt to use its leverage as an investor in these technologies to secure fair or affordable pricing of the final products for Canadians or for people living in low and middle income countries; and (j) did Canada attempt to use its leverage as an investor in these technologies to ensure access to the final products for Canadians or for people living in low and middle income countries, for example by requiring the products to be registered for use in Canada or in low and middle income countries? |
| Q-17502 — September 25, 2023 — Mr. Fast (Abbotsford) — With regard to Correctional Service Canada: what is the breakdown by security classification of the facility of how many dangerous offenders are currently in each type of facility, including those on parole or conditional release? |
| Q-17512 — September 25, 2023 — Mr. Fast (Abbotsford) — With regard to Correctional Service Canada: what is the breakdown by security classification of the facility of how many offenders serving life sentences for multiple murders are currently in each type of facility, including those on parole or conditional release? |
| Q-17522 — September 25, 2023 — Mr. Fast (Abbotsford) — With regard to the government’s response to drones being used in the proximity of penitentiaries or other correctional facilities, within the past five years: (a) has the government tested or used technology to jam or nullify mobile phone or drone use in relation to any penitentiary or correctional facility, and, if so, what are the details of what was done, including, for each action, the (i) date, (ii) summary of what was done; and (b) has the government consulted or sought external advice related to the drones being used to smuggle items into penitentiaries or correctional facilities, and, if so, what are the details, including the (i) name of the individual or firm, (ii) date, (iii) value of the contract, if applicable, (iv) description of the parameters for the advice or consultation sought, (v) description of the advice or information received? |
| Q-17532 — September 25, 2023 — Mr. Deltell (Louis-Saint-Laurent) — With regard to the government’s commitment to plant 2 billion trees by 2031: (a) what are the total expenditures to date in relation to the commitment; (b) how many trees have been planted to date; and (c) what is the projected number of trees to be planted under the commitment in (i) 2024, (ii) 2025, (iii) 2026, (iv) 2027, (v) 2028, (vi) 2029, (vii) 2030, (viii) 2031? |
| Q-17542 — September 25, 2023 — Mr. Lloyd (Sturgeon River—Parkland) — With regard to the upcoming tenth session of the Conference of the Parties (COP10) to the World Health Organization (WHO) Framework Convention on Tobacco Control, from November 10 to 25, 2023, and the third session of the Meeting of Parties (MOP3) to the Protocol to Eliminate Illicit Trade in Tobacco Products, from November 27 to 30, 2023: (a) how many individuals will be part of the government's delegation and what are their names and titles; (b) what is the overall budget for the government's COP10 and MOP3 participation, broken down by (i) accommodations, (ii) meals or per diems, (iii) hospitality; (c) what are the government's key priorities or action items for both the COP10 and MOP3; and (d) has the government been assigned any specific agenda items or resolutions for both the COP1O and MOP3, and, if so, what are they? |
| Q-17552 — September 25, 2023 — Mr. Steinley (Regina—Lewvan) — With regard to the Canada Child Benefit, during the most recent round of payments: (a) how many and what percentage of families who received payments got (i) the maximum payment amount for each child, (ii) a decreased payment amount due to the adjusted family net income level; and (b) of the families in (a) who received a decreased amount, what was the number and percentage of recipients that had their payments reduced by (i) less than 25 percent, (ii) 25 to 50 percent, (iii) more than 50 percent to 75 percent, (iv) more than 75 percent? |
| Q-17562 — September 25, 2023 — Mr. Johns (Courtenay—Alberni) — With regard to workplace and work-related injuries in the public sector, broken down by department and fiscal year since 2015-16: (a) what is the total number of public sector workers who experienced (i) physical injuries in the workplace, (ii) injuries to their mental health or mental well-being in the workplace; (b) how many of the workers in (a) experienced injuries that resulted in the worker being unable work either (i) temporarily, (ii) permanently, (iii) to the full extent of their job duties prior to their injury; (c) how many of the workers in (a) experienced injuries that resulted in a leave of work of (i) less than one month, (ii) one to three months, (iii) three to six months, (iv) six to twelve months, (v) twelve months or more; (d) of the workers who experienced injuries in (a), how many saw reduced or modified job duties for (i) less than one month, (ii) one to three months, (iii) three to six months, (iv) six to twelve months, (v) more than twelve months; and (e) how many workers in (a) were (i) permanently unable to work, (ii) unable to work in the same role, (iii) required to change work place or job title? |
| Q-17572 — September 25, 2023 — Mr. Davies (Vancouver Kingsway) — With regard to Transport Canada’s National Airports System: (a) what per-trip fees are charged to authorized providers of Ride App services, including (i) Lyft, (ii) Uber, (iii) KABU, by the Vancouver International Airport (YVR) and the Ottawa International Airport (YOW); (b) what is the total amount of fees collected by YVR and YOW from authorized providers of Ride App services, broken down by (i) airport, (ii) month, (iii) type, (iv) authorized provider; (c) what per-trip fees are charged to authorized taxi operators by YVR and YOW; and (d) what is the total amount of fees collected by YVR and YOW from authorized taxi operators, broken down by (i) airport, (ii) month, (iii) type, (iv) authorized operator? |
Notices of Motions for the Production of Papers |
|
Business of Supply |
|
Government Business |
|
Private Members' Notices of Motions |
|
Private Members' Business |
| S-222 — May 29, 2023 — Resuming consideration of the motion of Mr. Cannings (South Okanagan—West Kootenay), seconded by Ms. Kwan (Vancouver East), — That Bill S-222, An Act to amend the Department of Public Works and Government Services Act (use of wood), be now read a third time and do pass. |
| Pursuant to Standing Order 86(3), jointly seconded by: |
| Mr. Aldag (Cloverdale—Langley City) — October 7, 2022 |
| Debate — one hour remaining, pursuant to Standing Order 98(2). |
| Voting — at the expiry of the time provided for debate, pursuant to Standing Order 98(4). |
|
|
|
| 2 Response requested within 45 days |
|